Nikniaz, vitamin D meta analysis: 74% lower mortality [p=0.008] https://c19p.org/nikniaz
copied to clipboard
The impact of vitamin D supplementation on mortality rate and clinical outcomes of COVID-19 patients: A systematic review and meta-analysis
et al., Pharmaceutical Sciences, doi:10.34172/PS.2021.13
Meta analysis of 4 supplementation studies, finding that vitamin D supplementation "seems to decrease the mortality rate, the severity of the disease, and serum levels of the inflammatory markers". Mortality odds ratio OR 0.264, p = 0.008.Currently there are
82 vitamin D
for COVID-19 studies, showing 37% [25‑47%] lower mortality, 32% [4‑53%] lower ventilation, 50% [27‑65%] lower ICU admission, 20% [9‑29%] lower hospitalization, and 12% [2‑21%] lower cases.
|
risk of death, 73.6% lower, OR 0.26, p = 0.008, RR approximated with OR.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
Nikniaz et al., 3/9/2021, peer-reviewed, 4 authors.
Please send us corrections, updates, or comments. Vaccines and
treatments are both valuable and complementary. All practical, effective, and
safe means should be used. No treatment, vaccine, or intervention is 100%
available and effective for all current and future variants. Denying the
efficacy of any method increases mortality, morbidity, collateral damage, and
the risk of endemic status. We do not provide medical advice. Before taking
any medication, consult a qualified physician who can provide personalized
advice and details of risks and benefits based on your medical history and
situation. FLCCC and WCH
provide treatment protocols.